Video Shorts

Antibiotic Stewardship in Dermatology: Rethinking Prescribing Habits for Acne, Rosacea, and HS
1:44
Antibiotic Stewardship in Dermatology: Rethinking Prescribing Habits for Acne, Rosacea, and HS
5 months ago
by
Douglas DiRuggiero, DMSc, MHS, PA-C
New HAELO Phase 3 Data May Signal Paradigm Shift in HAE Treatment
0:58
New HAELO Phase 3 Data May Signal Paradigm Shift in HAE Treatment
5 months ago
by
Aleena Banerji, MD
Why Clinicians Should Stop Being Afraid to Treat Hemangiomas
1:05
Why Pediatricians Should Stop Being Afraid to Treat Hemangiomas
5 months ago
by
Lisa A. Swanson, MD
Why Your 'Normal' Thyroid Labs Might Be Lying to You
0:43
Why Your 'Normal' Thyroid Labs Might Be Lying to You
5 months ago
by
Rosemarie Lajara, MD
Image Credit: HCPLive
1:12
The Hidden Risk of Diabetes After Organ Transplant
5 months ago
by
Alan Hutchison, MD, PhD(+1 more)
How Extracellular Vesicles Are Revolutionizing Disease Prediction
0:43
How Extracellular Vesicles Are Revolutionizing Disease Prediction
5 months ago
by
Ernesto Nakayasu, MD
Chemical vs. Mineral Sunscreen: What You Need to Know
1:04
Chemical vs. Mineral Sunscreen: What You Need to Know
5 months ago
by
Hannah Rodriguez, MPAS, PA-C
Why Treat Peanut Allergy Before 1 Years Old?
1:15
Why Treat Peanut Allergy Before 1 Years Old?
5 months ago
by
Douglas P. Mack
Image Credit: HCPLive
1:23
Is Retatrutide The New Weight Loss Powerhouse?
5 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)
Breakthrough Results: Saraglitazar Shows 56.7% Response Rate
0:43
Saraglitazar Shows 56.7% Response Rate in PBC
5 months ago
by
Raj Vuppalanchi, MD
Long-Term Insulin Resistance Linked to Interstitial Lung Changes
1:12
Long-Term Insulin Resistance Linked to Interstitial Lung Changes
5 months ago
by
Sarath Raju, MD
Image Credit: HCPLive
1:09
Why Misinformation Spreads Faster than Truth
5 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+2 more)
A Myth About Skin Cancer and Patients of Color
1:09
A Myth About Skin Cancer and Patients of Color
5 months ago
by
Jeanine Downie, MD(+3 more)
Breakthrough Trial: 50% Reduction in Kidney Disease Relapse
0:43
Breakthrough Trial: 50% Reduction in Kidney Disease Relapse
5 months ago
by
Brendon Neuen, MBBS, PhD
Why We Need Diversity in Skin Cancer Prevention Media
0:48
Why We Need Diversity in Skin Cancer Prevention Media
5 months ago
by
Jeanine Downie, MD(+3 more)
Image Credit: HCPLive
1:12
Why Weight Loss Percentage Isn’t the Only Metric that Matters
5 months ago
by
W. Timothy Garvey, MD
Image Credit: HCPLive
1:04
Beyond Weight Loss: The New Era of Metabolic Health Drugs
5 months ago
by
Carel le Roux, PhD, MSC
Image Credit: HCPLive
0:57
Stop Looking at Numbers - Look for Patterns
5 months ago
by
Eugene Wright, Jr., MD(+2 more)
Phase 3b ENCORE: ALIS Achieves 88% Culture Conversion in MAC Lung Disease
1:07
Phase 3b ENCORE: ALIS Achieves 88% Culture Conversion in MAC Lung Disease
5 months ago
by
Charles L. Daley, MD
How to Help Your Child Talk About the Effects of Their Eczema
1:02
How to Help Your Child Talk About the Effects of Their Eczema
5 months ago
by
Delphine Kerob, MD
Linaclotide’s Expanded FDA Approval for Pediatric FC Patients
0:43
Linaclotide’s Expanded FDA Approval for Pediatric FC Patients
5 months ago
by
Julie Khlevner, MD, AGAF
Why We Must Talk to Kids About Skin Diseases
1:10
Why We Must Talk to Kids About Skin Diseases
5 months ago
by
Delphine Kerob, MD
Could an OTC Supplement Prevent Post-TB Deaths?
1:01
Could an OTC Supplement Prevent Post-TB Deaths?
5 months ago
by
Robert Wallis, MD
Breakthrough in Asthma: 4 Times Greater Remission Rates with Dupilumab
1:11
Breakthrough in Asthma: 4 Times Greater Remission Rates with Dupilumab
6 months ago
by
Simon Couillard, MD
The Future of HS Treatment: New Options and Innovations
1:10
The Future of HS Treatment: New Options and Innovations
6 months ago
by
Kiera Booth, MD
Phase 3 ADVANCE OUTCOMES: 55% Reduction in PAH Events With PAH
1:13
Phase 3 ADVANCE OUTCOMES: 55% Reduction in PAH Events With PAH
6 months ago
by
Vallerie McLaughlin, MD
New Phase 3 Amlitelimab Data: OX40 and Atopic Dermatitis
0:43
New Phase 3 Amlitelimab Data: OX40 and Atopic Dermatitis
6 months ago
by
Christopher G. Bunick, MD, PhD(+1 more)
Phase 2 ElevAATe: Can We Normalize Alpha-1 Levels?
0:58
Phase 2 ElevAATe: Can We Normalize Alpha-1 Levels?
6 months ago
by
Igor Barjaktarevic, MD, PhD
Image Credit: HCPLive
1:15
New Triple Agonist Drug Shows Bariatric-Level Weight Loss
6 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)
Image Credit: HCPLive
1:06
World's First Dual Glucose-Ketone Monitor Receives CE Mark
6 months ago
by
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES(+1 more)